Display Settings:

Format

Send to:

Choose Destination
    Arch Dis Child. 2001 May;84(5):432-3.

    Bronchoconstriction following nebulised colistin in cystic fibrosis.

    Source

    Portex Anaesthesia, Intensive Care and Respiratory Medicine, Great Ormond Street Hospital for Children, Great Ormond Street, London WC1N 3JH, UK. steve.cunningham@talk21.com

    Abstract

    Nebulised colistin is regularly used as antipseudomonal therapy in children with cystic fibrosis. We assessed bronchoconstriction in response to nebulised colistin in 58 children. Nebulised colistin significantly reduced FEV(1), MEF(25%), and SaO(2) for 15 minutes. In 20 children the reduction was greater than 10% from baseline FEV(1), and was still at that level in five at 30 minutes. Subjective assessment, baseline FEV(1), and serum IgE were unable to identify susceptible children. It is recommended that children receiving colistin should be carefully assessed for bronchoconstriction.

    PMID:
    11316693
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1718770
    Free PMC Article

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk